Literature DB >> 3456982

[Criteria for the interpretation of sensitivity testing of ofloxacin with the agar diffusion test].

H Grimm.   

Abstract

Regression analyses to determine the correlation of MIC and inhibition zone produced by ofloxacin disks were carried out using 300 freshly isolated cultures of infective organisms (20 strains each from 15 species). It was found in pilot studies that the correlation becomes poorer with increasing disk loads. Disks containing 5 micrograms of ofloxacin were chosen for comparative studies using Mueller-Hinton agar and Kirby-Bauer, as well as DIN-58940 methods. Based on preliminary MIC breakpoints of 1 and 4 mg/l and on calculations from regression equations, the following zone interpretations using the Kirby-Bauer method are recommended: resistant = up to 12 mm, intermediate = 13 to 19 mm, susceptible = 20 mm or more. The respective values for the DIN method are: resistant = up to 14 mm, intermediate = 15 to 21 mm, susceptible = 22 mm or more. The results are similar to those obtained by us in previous studies with norfloxacin, enoxacin and ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456982     DOI: 10.1007/BF01645192

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).

Authors:  D L Shungu; E Weinberg; H H Gadebusch
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

4.  Interpretive criteria for the agar diffusion susceptibility test with enoxacin.

Authors:  H Grimm
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

  4 in total
  2 in total

1.  [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].

Authors:  H Grimm
Journal:  Infection       Date:  1986       Impact factor: 3.553

2.  Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection.

Authors:  Sandra-Maria Wienhold; Markus C Brack; Geraldine Nouailles; Gopinath Krishnamoorthy; Imke H E Korf; Claudius Seitz; Sarah Wienecke; Kristina Dietert; Corinne Gurtner; Olivia Kershaw; Achim D Gruber; Anton Ross; Holger Ziehr; Manfred Rohde; Jens Neudecker; Jasmin Lienau; Norbert Suttorp; Stefan Hippenstiel; Andreas C Hocke; Christine Rohde; Martin Witzenrath
Journal:  Viruses       Date:  2021-12-24       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.